Kyle Matthew Kampman

NIH Rank #2911
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1883848Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Psychiatry

NIH Funding · FY2025

Linked Award Amount
$3.3M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#2,911
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Kyle Matthew Kampman as a PI. Multi-PI records show the full award amount for context.

  • 5UH3DA049694-04UH3
    Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
    $2.6M
    award amount
  • 5R61DA061206-02R61
    Psilocybin: Capturing brain mechanisms of motivation and neurocognition in individuals with opioid use disorder
    $472.1K
    award amount
  • 5R34DA057507-03R34
    Rapid outpatient low-dose initiation of buprenorphine for individuals with OUD using fentanyl
    $230K
    award amount

Award organization

Organizations that administered FY2025 awards listing Kyle Matthew Kampman as a PI.

FY2025 award administered by University of Pennsylvania (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    ScienceDex Coverage Begins
    Earliest loaded PI award records: FY2024
  2. 2024
    $500K Cumulative Linked Award Amount
  3. 2024
    $1M Cumulative Linked Award Amount
  4. 2024
    $2M Cumulative Linked Award Amount
  5. 2024
    $5M Cumulative Linked Award Amount
  6. 2024
    Reached Top 50% by Award-Linked Rank
    Ranked #829
  7. 2024
    Reached Top 25% by Award-Linked Rank
    Ranked #829
  8. 2024
    Reached Top 10% by Award-Linked Rank
    Ranked #829
  9. 2024
    Reached Top 5% by Award-Linked Rank
    Ranked #829